IBDEI11L ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16941,0)
;;=K76.0^^61^778^12
;;^UTILITY(U,$J,358.3,16941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16941,1,3,0)
;;=3^Fatty Liver NEC
;;^UTILITY(U,$J,358.3,16941,1,4,0)
;;=4^K76.0
;;^UTILITY(U,$J,358.3,16941,2)
;;=^5008831
;;^UTILITY(U,$J,358.3,16942,0)
;;=K76.89^^61^778^20
;;^UTILITY(U,$J,358.3,16942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16942,1,3,0)
;;=3^Liver Disease NEC
;;^UTILITY(U,$J,358.3,16942,1,4,0)
;;=4^K76.89
;;^UTILITY(U,$J,358.3,16942,2)
;;=^5008835
;;^UTILITY(U,$J,358.3,16943,0)
;;=K71.6^^61^778^34
;;^UTILITY(U,$J,358.3,16943,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16943,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatitis NEC
;;^UTILITY(U,$J,358.3,16943,1,4,0)
;;=4^K71.6
;;^UTILITY(U,$J,358.3,16943,2)
;;=^5008801
;;^UTILITY(U,$J,358.3,16944,0)
;;=K75.9^^61^778^19
;;^UTILITY(U,$J,358.3,16944,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16944,1,3,0)
;;=3^Inflammatory Liver Disease,Unspec
;;^UTILITY(U,$J,358.3,16944,1,4,0)
;;=4^K75.9
;;^UTILITY(U,$J,358.3,16944,2)
;;=^5008830
;;^UTILITY(U,$J,358.3,16945,0)
;;=K71.0^^61^778^26
;;^UTILITY(U,$J,358.3,16945,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16945,1,3,0)
;;=3^Toxic Liver Disease w/ Cholestasis
;;^UTILITY(U,$J,358.3,16945,1,4,0)
;;=4^K71.0
;;^UTILITY(U,$J,358.3,16945,2)
;;=^5008793
;;^UTILITY(U,$J,358.3,16946,0)
;;=K71.10^^61^778^32
;;^UTILITY(U,$J,358.3,16946,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16946,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
;;^UTILITY(U,$J,358.3,16946,1,4,0)
;;=4^K71.10
;;^UTILITY(U,$J,358.3,16946,2)
;;=^5008794
;;^UTILITY(U,$J,358.3,16947,0)
;;=K71.11^^61^778^33
;;^UTILITY(U,$J,358.3,16947,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16947,1,3,0)
;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
;;^UTILITY(U,$J,358.3,16947,1,4,0)
;;=4^K71.11
;;^UTILITY(U,$J,358.3,16947,2)
;;=^5008795
;;^UTILITY(U,$J,358.3,16948,0)
;;=K71.2^^61^778^25
;;^UTILITY(U,$J,358.3,16948,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16948,1,3,0)
;;=3^Toxic Liver Disease w/ Acute Hepatitis
;;^UTILITY(U,$J,358.3,16948,1,4,0)
;;=4^K71.2
;;^UTILITY(U,$J,358.3,16948,2)
;;=^5008796
;;^UTILITY(U,$J,358.3,16949,0)
;;=K71.3^^61^778^30
;;^UTILITY(U,$J,358.3,16949,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16949,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
;;^UTILITY(U,$J,358.3,16949,1,4,0)
;;=4^K71.3
;;^UTILITY(U,$J,358.3,16949,2)
;;=^5008797
;;^UTILITY(U,$J,358.3,16950,0)
;;=K71.4^^61^778^29
;;^UTILITY(U,$J,358.3,16950,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16950,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
;;^UTILITY(U,$J,358.3,16950,1,4,0)
;;=4^K71.4
;;^UTILITY(U,$J,358.3,16950,2)
;;=^5008798
;;^UTILITY(U,$J,358.3,16951,0)
;;=K75.81^^61^778^21
;;^UTILITY(U,$J,358.3,16951,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16951,1,3,0)
;;=3^Nonalcoholic Steatohepatitis (NASH)
;;^UTILITY(U,$J,358.3,16951,1,4,0)
;;=4^K75.81
;;^UTILITY(U,$J,358.3,16951,2)
;;=^5008828
;;^UTILITY(U,$J,358.3,16952,0)
;;=K75.89^^61^778^18
;;^UTILITY(U,$J,358.3,16952,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16952,1,3,0)
;;=3^Inflammatory Liver Disease,Oth Spec
;;^UTILITY(U,$J,358.3,16952,1,4,0)
;;=4^K75.89
;;^UTILITY(U,$J,358.3,16952,2)
;;=^5008829
;;^UTILITY(U,$J,358.3,16953,0)
;;=K76.4^^61^778^23
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI11L 3770 printed Sep 23, 2025@19:35:58 Page 2
IBDEI11L ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16941,0)
+2 ;;=K76.0^^61^778^12
+3 ;;^UTILITY(U,$J,358.3,16941,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,16941,1,3,0)
+6 ;;=3^Fatty Liver NEC
+7 ;;^UTILITY(U,$J,358.3,16941,1,4,0)
+8 ;;=4^K76.0
+9 ;;^UTILITY(U,$J,358.3,16941,2)
+10 ;;=^5008831
+11 ;;^UTILITY(U,$J,358.3,16942,0)
+12 ;;=K76.89^^61^778^20
+13 ;;^UTILITY(U,$J,358.3,16942,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,16942,1,3,0)
+16 ;;=3^Liver Disease NEC
+17 ;;^UTILITY(U,$J,358.3,16942,1,4,0)
+18 ;;=4^K76.89
+19 ;;^UTILITY(U,$J,358.3,16942,2)
+20 ;;=^5008835
+21 ;;^UTILITY(U,$J,358.3,16943,0)
+22 ;;=K71.6^^61^778^34
+23 ;;^UTILITY(U,$J,358.3,16943,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,16943,1,3,0)
+26 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
+27 ;;^UTILITY(U,$J,358.3,16943,1,4,0)
+28 ;;=4^K71.6
+29 ;;^UTILITY(U,$J,358.3,16943,2)
+30 ;;=^5008801
+31 ;;^UTILITY(U,$J,358.3,16944,0)
+32 ;;=K75.9^^61^778^19
+33 ;;^UTILITY(U,$J,358.3,16944,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,16944,1,3,0)
+36 ;;=3^Inflammatory Liver Disease,Unspec
+37 ;;^UTILITY(U,$J,358.3,16944,1,4,0)
+38 ;;=4^K75.9
+39 ;;^UTILITY(U,$J,358.3,16944,2)
+40 ;;=^5008830
+41 ;;^UTILITY(U,$J,358.3,16945,0)
+42 ;;=K71.0^^61^778^26
+43 ;;^UTILITY(U,$J,358.3,16945,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,16945,1,3,0)
+46 ;;=3^Toxic Liver Disease w/ Cholestasis
+47 ;;^UTILITY(U,$J,358.3,16945,1,4,0)
+48 ;;=4^K71.0
+49 ;;^UTILITY(U,$J,358.3,16945,2)
+50 ;;=^5008793
+51 ;;^UTILITY(U,$J,358.3,16946,0)
+52 ;;=K71.10^^61^778^32
+53 ;;^UTILITY(U,$J,358.3,16946,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,16946,1,3,0)
+56 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
+57 ;;^UTILITY(U,$J,358.3,16946,1,4,0)
+58 ;;=4^K71.10
+59 ;;^UTILITY(U,$J,358.3,16946,2)
+60 ;;=^5008794
+61 ;;^UTILITY(U,$J,358.3,16947,0)
+62 ;;=K71.11^^61^778^33
+63 ;;^UTILITY(U,$J,358.3,16947,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,16947,1,3,0)
+66 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
+67 ;;^UTILITY(U,$J,358.3,16947,1,4,0)
+68 ;;=4^K71.11
+69 ;;^UTILITY(U,$J,358.3,16947,2)
+70 ;;=^5008795
+71 ;;^UTILITY(U,$J,358.3,16948,0)
+72 ;;=K71.2^^61^778^25
+73 ;;^UTILITY(U,$J,358.3,16948,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,16948,1,3,0)
+76 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
+77 ;;^UTILITY(U,$J,358.3,16948,1,4,0)
+78 ;;=4^K71.2
+79 ;;^UTILITY(U,$J,358.3,16948,2)
+80 ;;=^5008796
+81 ;;^UTILITY(U,$J,358.3,16949,0)
+82 ;;=K71.3^^61^778^30
+83 ;;^UTILITY(U,$J,358.3,16949,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,16949,1,3,0)
+86 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
+87 ;;^UTILITY(U,$J,358.3,16949,1,4,0)
+88 ;;=4^K71.3
+89 ;;^UTILITY(U,$J,358.3,16949,2)
+90 ;;=^5008797
+91 ;;^UTILITY(U,$J,358.3,16950,0)
+92 ;;=K71.4^^61^778^29
+93 ;;^UTILITY(U,$J,358.3,16950,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,16950,1,3,0)
+96 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
+97 ;;^UTILITY(U,$J,358.3,16950,1,4,0)
+98 ;;=4^K71.4
+99 ;;^UTILITY(U,$J,358.3,16950,2)
+100 ;;=^5008798
+101 ;;^UTILITY(U,$J,358.3,16951,0)
+102 ;;=K75.81^^61^778^21
+103 ;;^UTILITY(U,$J,358.3,16951,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,16951,1,3,0)
+106 ;;=3^Nonalcoholic Steatohepatitis (NASH)
+107 ;;^UTILITY(U,$J,358.3,16951,1,4,0)
+108 ;;=4^K75.81
+109 ;;^UTILITY(U,$J,358.3,16951,2)
+110 ;;=^5008828
+111 ;;^UTILITY(U,$J,358.3,16952,0)
+112 ;;=K75.89^^61^778^18
+113 ;;^UTILITY(U,$J,358.3,16952,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,16952,1,3,0)
+116 ;;=3^Inflammatory Liver Disease,Oth Spec
+117 ;;^UTILITY(U,$J,358.3,16952,1,4,0)
+118 ;;=4^K75.89
+119 ;;^UTILITY(U,$J,358.3,16952,2)
+120 ;;=^5008829
+121 ;;^UTILITY(U,$J,358.3,16953,0)
+122 ;;=K76.4^^61^778^23
